Khoso Baluch

Insider Reports History

Location
Bedminster, NJ
Signature
/s/ Khoso Baluch by John J. Wolfel, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Khoso Baluch:

Company Role Class Num Shares Value Price $ Report Date Ownership
Longeveron Inc. Director Class A Common Stock 52,516 $43,588 $0.8300 11 Aug 2025 Direct
Processa Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 300,000 01 Oct 2025 Direct
Processa Pharmaceuticals, Inc. Director Restricted Stock 206,505 24 Jul 2025 Direct
Processa Pharmaceuticals, Inc. Director Restricted Stock Units 100,000 01 Oct 2025 Direct
Longeveron Inc. Director Warrant (right to buy) 29,415 11 Aug 2025 Direct

Insider Reports Filed by Khoso Baluch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCSA Processa Pharmaceuticals, Inc. 01 Oct 2025 2 $0 4 Director 03 Oct 2025, 16:39
LGVN Longeveron Inc. 11 Aug 2025 2 $0 4 Director 13 Aug 2025, 18:00
PCSA Processa Pharmaceuticals, Inc. 24 Jul 2025 1 $0 4/A Director 18 Sep 2025, 16:12
LGVN Longeveron Inc. 15 Jul 2025 1 $0 4 Director 17 Jul 2025, 19:45
LGVN Longeveron Inc. 02 Dec 2024 1 -$2,588 4 Director 04 Dec 2024, 18:00
PCSA Processa Pharmaceuticals, Inc. 03 Sep 2024 1 $0 4 Director 18 Sep 2024, 16:47
LGVN Longeveron Inc. 15 Aug 2024 1 $0 4 Director 19 Aug 2024, 20:30
LGVN Longeveron Inc. 09 Jun 2024 1 -$132 4 Director 11 Jun 2024, 17:00
LGVN Longeveron Inc. 28 Dec 2023 2 +$14,257 4 Director 02 Jan 2024, 18:00
LGVN Longeveron Inc. 21 Dec 2023 1 $0 4 Director 26 Dec 2023, 18:00
PCSA Processa Pharmaceuticals, Inc. 27 Jun 2023 3 $0 4 Director 24 Jul 2023, 18:29
LGVN Longeveron Inc. 09 Jun 2023 1 $0 4 Director 12 Jun 2023, 17:15
LGVN Longeveron Inc. 09 Jun 2023 0 $0 3 Director 12 Jun 2023, 17:00
PCSA Processa Pharmaceuticals, Inc. 09 Feb 2023 1 +$10,000 4 Director 10 Feb 2023, 16:18
PCSA Processa Pharmaceuticals, Inc. 12 Jul 2022 1 $0 4 Director 14 Jul 2022, 16:24
PCSA Processa Pharmaceuticals, Inc. 11 Jul 2022 0 $0 3/A Director 12 Jul 2022, 16:26